Certain mutations in the COL1A1 and COL1A2 genes produce clinical symptoms of both osteogenesis imperfecta (OI) and Ehlers-Danlos syndrome (EDS) that include abnormal craniofacial growth, dental malocclusion, and dentinogenesis imperfecta. A mouse model (Col1a1(Jrt)/+) was recently developed that had a skeletal phenotype and other features consistent with moderate-to-severe OI and also with EDS. The craniofacial phenotype of 4- and 20-wk-old Col1a1(Jrt)/+ mice and wild-type littermates was assessed by micro-computed tomography (µCT) and morphometry. Teeth and the periodontal ligament compartment were analyzed by µCT, light microscopy/histomorphometry, and electron microscopy. Over time, at 20 wk, Col1a1(Jrt)/+ mice developed smaller heads, a shortened anterior cranial base, class III occlusion, and a mandibular side shift with shorter morphology in the masticatory region (maxilla and mandible). Col1a1(Jrt)/+ mice also had changes in the periodontal compartment and abnormalities in the dentin matrix and mineralization. These findings validate Col1a1(Jrt)/+ mice as a model for OI and EDS in humans.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1177/0022034516637045 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Development of a facile method to compute collagen network pathological anisotropy using AFM imaging.
Sci Rep
November 2023
Faculty of Dentistry, University of Toronto, 124 Edward Street, Toronto, ON, M5G 1G6, Canada.
Article Synopsis
- Type I collagen is a crucial component of the extracellular matrix, providing strength and stability to various tissues like tendons, bones, and skin.
- The study presents a new method that uses Fast Fourier Transform (FFT) and Atomic Force Microscopy (AFM) to analyze collagen fibril morphology at the nanoscale, enhancing our understanding of collagen-related diseases.
- Findings from examining collagen in Ehlers Danlos Syndrome (EDS) revealed significant morphological differences, suggesting that this approach can aid in diagnosing connective tissue disorders.
Effect of sclerostin inactivation in a mouse model of severe dominant osteogenesis imperfecta.
Sci Rep
March 2023
Shriners Hospital for Children, 1003 Decarie, Montreal, QC, H4A 0A9, Canada.
Osteogenesis imperfecta (OI) is a rare bone disease that is associated with fractures and low bone mass. Sclerostin inhibition is being evaluated as a potential approach to increase bone mass in OI. We had previously found that in Col1a1 mice, a model of severe OI, treatment with an anti-sclerostin antibody had a minor effect on the skeletal phenotype.
View Article and Find Full Text PDFTendon properties in a mouse model of severe osteogenesis imperfecta.
Connect Tissue Res
May 2023
Motion Analysis Center, Shriners Hospitals for Children - Canada, Montreal, Quebec, Canada.
Purpose/aim Of The Study: Osteogenesis imperfecta is a heritable bone disorder that is usually caused by mutations in collagen type I encoding genes. The impact of such mutations on tendons, a structure with high collagen type I content, remains largely unexplored. We hypothesized that tendon properties are abnormal in the context of a mutation affecting collagen type I.
View Article and Find Full Text PDFMuscle-bone properties after prolonged voluntary wheel running in a mouse model of dominant severe osteogenesis imperfecta.
J Musculoskelet Neuronal Interact
December 2021
Shriners Hospital for Children-Canada, Montreal, Quebec, Canada.
Objective: The objective of the current study is to assess the effect of a seven-week voluntary wheel running intervention on muscles and bones properties in a mouse model mimicking dominant severe osteogenesis imperfecta (OI).
Methods: Female wild-type (WT) and OI (Col1a1) mice either performed voluntarily wheel-running exercise for 7-weeks or remained sedentary. Running distance and speed, forelimb grip strength, isolated muscle force and fatigability as well as bone morphology and mechanical properties were assessed.
Sclerostin-Antibody Treatment Decreases Fracture Rates in Axial Skeleton and Improves the Skeletal Phenotype in Growing oim/oim Mice.
Calcif Tissue Int
May 2020
Pole of Rheumatology, Institut de Recherche Expérimentale et Clinique, UCLouvain, Brussels, Belgium.
In osteogenesis imperfecta (OI), vertebrae brittleness causes thorax deformations and leads to cardiopulmonary failure. As sclerostin-neutralizing antibodies increase bone mass and strength in animal models of osteoporosis, their administration in two murine models of severe OI enhanced the strength of vertebrae in growing female Crtap mice but not in growing male Col1a1 mice. However, these two studies ignored the impact of antibodies on spine growth, fracture rates, and compressive mechanical properties.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!